Editorial Commentary: Arthroscopic Debridement of Tennis Elbow Nonresponsive to Nonoperative Measures Is a Good Option and Clinical Outcomes Are Associated With Radiographic Outcomes

Arthroscopy. 2022 Dec;38(12):3130-3132. doi: 10.1016/j.arthro.2022.09.005.

Abstract

Chronic lateral epicondylitis, or "tennis elbow," is rare and affects 1% to 3% of adults annually. The initial treatment should be nonoperative and include physical therapy, nonsteroidal anti-inflammatory medication, rest, bracing, extracorporeal shock wave therapy, and injection therapy with various agents such as autologous blood, dextrose, corticosteroids, or platelet-rich plasma. The condition is self-limited, and approximately 80% of cases resolve. In refractory cases, arthroscopic release with debridement is a good surgical option but is not superior to open or percutaneous techniques. Recent research shows that a reduction in magnetic resonance imaging signal intensity in patients who respond to arthroscopic treatment correlates with pain reduction and functional outcome improvement.

Publication types

  • Editorial
  • Comment

MeSH terms

  • Adult
  • Anti-Inflammatory Agents, Non-Steroidal
  • Debridement
  • Extracorporeal Shockwave Therapy*
  • Humans
  • Platelet-Rich Plasma*
  • Tennis Elbow* / diagnostic imaging
  • Tennis Elbow* / surgery

Substances

  • Anti-Inflammatory Agents, Non-Steroidal